SpyGlass Pharma (SGP) Treasury Shares (2024 - 2025)
SpyGlass Pharma (SGP) posted quarterly Treasury Shares of $20.3 million for Q4 2025, up 111.7% year-over-year from $9.6 million in Q4 2024, and up 111.7% quarter-over-quarter from $9.6 million in Q4 2024.
SpyGlass Pharma (SGP) Treasury Shares (2024 - 2025) Analysis & Trends
SpyGlass Pharma (SGP) has reported Treasury Shares for 2 consecutive years, with $20.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares rose 111.7% year-over-year to $20.3 million; the TTM figure through Dec 2025 stood at $20.3 million (up 111.7% YoY), while the FY2025 annual figure was $20.3 million, up 111.7% from the prior year.
- Treasury Shares advanced to $20.3 million in Q4 2025 per SGP's latest filing, from $9.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $20.3 million in Q4 2025 and bottomed at $9.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | SpyGlass Pharma | 876.29 Mn | 876.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.34 Mn |
| Dec 31, 2025 | 20.34 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Dec 31, 2024 | 9.61 Mn |